At Nouvogenes Therapeutics, we are driven by a bold vision: to transform the treatment of chronic diseases through precision gene editing. Using cutting-edge CRISPR technology, our clinical-stage therapies target the root cause of conditions, offering not just incremental improvements, but the possibility of a one-time treatment that could free patients from a lifetime of care, complications, and clinical dependency. With a growing pipeline of gene therapy candidates, we are committed to advancing science that restores health, reduces suffering, and redefines what’s possible for patients.